Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-056143

EVP, Research & CSO sold 3,805 shares at $35.04 ($133,335)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-10-27 Option exercise +3,805 $1.53 $5,822 27,505 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2020-10-27 Sale −3,805 $35.04 $133,335 23,700 D: show line 2 in the form
Open-market sales · 3,805 sh · avg $35.04 · $133,335

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-10-27 Option exercise · Stock Option (Right to Buy) −3,805 450,510 D: show line 3 in the form
Loading xslF345X03/doc4.xml…